Connect with us

Industry

Isle of Man pharmacies to trial dispensing medical cannabis products

Patients may soon be able to access their prescriptions through a local pharmacy.

Published

on

Isle of Man pharmacies to trial dispensing medical cannabis products
The Department of Health and Social Care is looking to partner with an on-island community pharmacy

Medical cannabis patients on the Isle of Man may soon be able to access their prescriptions through a local pharmacy, under a new Government pilot scheme.

The Department of Health and Social Care is looking to partner with an on-island community pharmacy, to trial an import and dispensing service for Cannabis Based Medicinal Products (CBMP). 

This means that patients with private prescriptions for medicinal cannabis products will be able to access products on the island, through a “quality assured and accredited dispensary process”. 

A public consultation in 2019 showed overwhelming support for providing a route through which patients could obtain cannabis based medicinal products on prescription.

MyAccess clinics banner

But currently patients who hold prescriptions on the Isle of Man are required to import their medication, which is distributed by cannabis dispensaries in the UK.  

The Government now is seeking an on island pharmacy based service to operate the scheme as a pilot for a minimum of 12 months, as the “next stage in the journey” of enabling patients to access these medicines.

According to an official release from the Department of Health, alongside the importation and dispensing of products, the pharmacy will play a key role in developing a robust governance process and in helping collect data and evidence of current needs to shape future services.  

Read more: Proposal for medical cannabis facility put forward on Isle of Man 

A statement on the Government website said: “Isle of Man residents seeking medical cannabis will need to do so via a private prescription from a private clinic in the United Kingdom or Crown Dependencies, by clinicians who are on the Specialist Register of the General Medical Council (GMC) and who can prescribe such products.   

“At this time prescriptions for any CBMP will not be available on the NHS from the Department or Manx Care, as the NHS on the Island does not routinely fund non-NICE approved treatments. Residents will be personally responsible for paying for these private prescriptions.”

Any pharmacy interested in providing this local service is  invited to respond through the online procurement portal. Full details of the requirements and expectations can be found here

The closing date for applications is 20 April, 2022.

Home » Industry » Isle of Man pharmacies to trial dispensing medical cannabis products

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.